DOCSLIB.ORG

Lists of Narcotic Drugs, Psychotropic Substances and Precursors, Turnover of Which on the Territory of Azerbaijan Republic Is Prohibited, Restricted and Controlled

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Lists of Narcotic Drugs, Psychotropic Substances and Precursors, Turnover of Which on the Territory of Azerbaijan Republic Is Prohibited, Restricted and Controlled Lists of narcotic drugs, psychotropic substances and precursors, turnover of which on the territory of Azerbaijan Republic is prohibited, restricted and controlled. List I. Narcotic drugs, psychotropic substances and precursors, turnover of which on the territory of Azerbaijan Republic is prohibited. Narcotic drugs, turnover of which on the territory of Azerbaijan Republic is prohibited: 1. Alilprodine 2. Alphameprodin 3. Alphametadol 4. Alpha-methylfentanyl 5. Alpha-methylthiofentanyl 6. Alphaprodine 7. Alphasethylmetadol 8. Alfentanyl 9. Anileridine 10. Acetorfine 11. Acetyl-alpha-methylfentanyl 12. Acetyldihydrocodeine 13. Acetylmetadol 14. Benzetidine 15. Bernzoilmorphine 16. Benzylmorphine 17. Betacetylmetadol 18. Beta-hydroxyifentanyl 19. Beta-hydroxy-3-methylfentanyl 20. Betameprodine 21. Betametadol 22. Betaprodine 23. Bezitramide 24. Dextromoramid 25. Dextropropoxifen 26. Dezomorphine 27. Diampromyd 28. Diethyltiambuten 29. Diphenoxine 30. Diphenoxylate 31. Dihydrocodeine 32. Dihydromorphine 33. Dimepeptanol 34. Dimethyltiambuten4 35. Dioxafethyl butyrate 36. Dimenoxadol 37. Dipipanon 38. Drotebanol 39. Ecgonine 40. Ethylmethyltiambuten 41. Etonitazen 42. Etorphine 43. Etokseridin 44. Fenadokson 45. Fenampromide 46. Fenazosin 47. Fenomorphane 48. Fenoperidine 49. Folkodin 50. Furetidin 51. Heroin 52. Hydrokodon 53. Hydromorphineol 54. Hydromorphone 55. Hydromorphine-N-oxide 56. Hydroxypethidine 57. Izometadone 58. Cannabis 59. Ketobemidone 60. Klonitazen 61. Coca leafs 62. Cocaine 63. Codeine-N-oxsid 64. Kodoxyme 65. Levometorphan 66. Levomoramide 67. Levofenasilmorphane 68. Levorfanol 69. Metazosine 70. Methyldezorphine 71. Methyldihydromorphine 72. 3-methylfentanyl 73. 3-methyltiofentanyl 74. Metopon 75. Mirofin 76. Moramid intermediate 77. Morferidin 78. Morphine metobromid 79. Morphine-N-oksid 80. MPPP 81. Nikokodin 82. Nikadicodine 83. Nikomorphine 84. Norasetimetadol 85. Norcodeine 86. Norleforfanol 87. Normetadon 88. Normorphine 89. Norpipapon 90. Oksikodon 91. Oksimorfon 92. Para-Fluorofentanyl 93 PEPAP 94. Pethidine intermediate A 95. Pethidine intermediate B 96. Pethidine intermediate C 97. Piminodine 98. Proheptazine 99. Properidine 100. Propiram 101. Rasemetorphane 102. Rasemoramid 103. Rasemorphane 104. Sufentanyl 105. Tebaine 106. Tebakon 107. Tiofentanyl 108. Tiryak (opium) 109. Tilidin 1.1. Import of narcotic drugs, specified in this list, to the Azerbaijan Republic under other names and also all their salts and compounds is prohibited. Psychotropic substances, turnover of which on the territory of Azerbaijan Republic is prohibited: 1. Brolamphetamine DOB 2. DMA 3. DMQP 4. DMT 5. DOET 6. DET 7. Catinon 8. (+)-Lizerqid LRD LSD-25 9. MDMA 10. Meskalin 11. 4-methylaminoreks 12. MMDA 13. N-ethyl MDA 14. N-hydroxyl MDA 15. Paragexyl 16. PMA 17. Psilocin, Psilocin 18. Psilocybin 19 Rolisiklidin, FSP 20. STP, DOM 21. TMA 22. Tenamphetamine MDA 23. Tenosiklidin TSP 24. Tetrahydrocannabinol 25. Etisiklidin FSQ 26. Etriptamine 27. Amphetamine 28. Deksametamine 29. Delta-9-tetrahydrocannabinol 30. Levamphetamine 31. Levometamphetamine 32. Meklokvalon 33. Metamphetamine 34. Methylfenidat 35. Rasemat metamphetamine 36. Sekobarbital 37. Fenethyllin 38. Fenmetrazin 39. Fensiklidin FSP 40. Sipeprol 41. Amobarbital 42. Butalbital 43. Catine 44. Ethyl loflazepat 45. Ethylamphetamine 46. Etinamat 47. Etxlorvinol 48. Allobarbital 49. Benzfetamine 50. Brotizolam 51. Butobarbital 52. Vinylbital 53. Haloxazolam 54. Delorazepam 55. Kloxazolam 56. Klorazepat 57. Lefetamin, SPA 58. Lormetazepam 59. Mazindol 60. Mezokarb 61. Methylfenobarbital 62. Metiprilon 63. Nimetazepam 64. Nordazepam 65. Pemolin 66. Pinazepam 67. Pipradrol 68. Pirovaleron 69. Prazepam 70. Sekbutabarbital 71. Fendimetrazin 72. Fenkamfamin 73. Fenproporex 74. Fentermin 75. Amfepramon 76. Metakvalon 77. Siklobarbital 78. Klotiazepam 2.1. Import of psychotropic substances, specified in this list, to the Azerbaijan Republic under other names and also all their salts and compounds is prohibited. Precursors, turnover of which on the territory of Azerbaijan Republic is prohibited: 1. Anthranyl acid 2. Phenylacetic acid 3. 1-phenyl-2 propanon 4. Izosafrol 5. Lysergic acid 6. Methylethylketon 7. 3, 4 methylendioxyphenile 2-propanon 8. N-acetylanthranyl acid 9. Piperidin 10. Piperonal 11. Safrole 3.1. Import of precursors, specified in this list, to the Azerbaijan Republic under other names and also all their salts and compounds is prohibited. List II. Narcotic drugs, psychotropic substances and precursors, turnover of which on the territory of Azerbaijan Republic is restricted. Narcotic drugs, turnover of which on the territory of Azerbaijan Republic is restricted: 1. Buprenorphine 2. Butorphanol (stadol) 3. Ethylmorphine hydrochloride (dionine) 4. Fentanyl 5. Metadon 6. Methylmorpine (codeine) (in composition of other pharmaceutical products of compound composition is not controlled) 7. Methylmorphine phosphate (codeine phosphate) 8. Morphine 9. Morphine hydrochloride 10. Morphine sulphate 11. Pantopon (omnopon) 12. Pentazosin 13. Pritramid (dipidolor) 14. Propanidid (sombrevin) 15. Tramadol (tramal) 16. Trimeperidin (promedol) 1.1. Import of narcotic drugs, specified in this list, to Azerbaijan Republic under other names and also all their salts and compounds is prohibited. 1.2. narcotic drugs, specified in this list may be imported to Azerbaijan Republic only by the governmental authorities. Psychotropic substances, turnover of which on the territory of Azerbaijan Republic is restricted: 1. Alprazolam 2. Aminoreks 3. Estazolam 4. Phenobarbital (in composition of other pharmaceutical products of compound composition is not restricted and controlled) 5. Ketazolam 6. Klobazam 7. Qlyutetimid 8. Temazepam 9. Triazolam 2.1. Import of psychotropic substances, specified in this list, to Azerbaijan Republic under other names and also all their salts and compounds is prohibited. 2.2. Psychotropic substances, specified in this list may be imported to Azerbaijan Republic only by the governmental authorities. Precursors, turnover of which on the territory of Azerbaijan Republic is restricted: 1. Erqometrin (qr) 2. Erqotamin (qr) 3. Ethylic ether 4. Pseudoephedrine 5. Acetic acid anhydride 3.1. Import of precursors, specified in this list, to Azerbaijan Republic under other names and also all their salts and compounds is prohibited. 3.2. Precursors, specified in this list may be imported to Azerbaijan Republic only by the governmental authorities. List III. Psychotropic substances and precursors, turnover of which on the territory of Azerbaijan Republic is controlled. Psychotropic substances, turnover of which on the territory of Azerbaijan Republic is controlled: 1. Barbital 2. Bromazepam 3. Diazepam 4. Fludiazepam 5. Flunitrazepam 6. Flurazepam 7. Chlordiazepoxide 8. Kamazepam 9. Ketamine 10. Klonazepam 11. Halothane 12. Halozepam 13. Lorazepam 14. Loprazolam 15. Medazepam 16. Meprobamat 17. Mefenorex 18. Midazolan 19. Natrium oxybutyrate 20. Nitrozepam 21. Oxazepam 22. Oxazolam 23. Pentobarbital 24. Tetrazepam 1.1. Import of psychotropic substances, specified in this list, to Azerbaijan Republic without indication of their international names, under any other names is prohibited. Precursors, turnover of which on the territory of Azerbaijan Republic is controlled: 1. Acetone 2. Efedrin (kq) (in composition of other pharmaceutical products of compound composition is not controlled) 3. Chlorous acid 4. Kalium permanqanat 5. Sulphuric acid 6. Toluol 2.1. Import of precursors, specified in this list, to Azerbaijan Republic under any other names is prohibited. .
Load more

Recommended publications
  • The In¯Uence of Medication on Erectile Function
    International Journal of Impotence Research (1997) 9, 17±26 ß 1997 Stockton Press All rights reserved 0955-9930/97 $12.00 The in¯uence of medication on erectile function W Meinhardt1, RF Kropman2, P Vermeij3, AAB Lycklama aÁ Nijeholt4 and J Zwartendijk4 1Department of Urology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; 2Department of Urology, Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands; 3Pharmacy; and 4Department of Urology, Leiden University Hospital, P.O. Box 9600, 2300 RC Leiden, The Netherlands Keywords: impotence; side-effect; antipsychotic; antihypertensive; physiology; erectile function Introduction stopped their antihypertensive treatment over a ®ve year period, because of side-effects on sexual function.5 In the drug registration procedures sexual Several physiological mechanisms are involved in function is not a major issue. This means that erectile function. A negative in¯uence of prescrip- knowledge of the problem is mainly dependent on tion-drugs on these mechanisms will not always case reports and the lists from side effect registries.6±8 come to the attention of the clinician, whereas a Another way of looking at the problem is drug causing priapism will rarely escape the atten- combining available data on mechanisms of action tion. of drugs with the knowledge of the physiological When erectile function is in¯uenced in a negative mechanisms involved in erectile function. The way compensation may occur. For example, age- advantage of this approach is that remedies may related penile sensory disorders may be compen- evolve from it. sated for by extra stimulation.1 Diminished in¯ux of In this paper we will discuss the subject in the blood will lead to a slower onset of the erection, but following order: may be accepted.
    [Show full text]
  • Drug and Medication Classification Schedule
    KENTUCKY HORSE RACING COMMISSION UNIFORM DRUG, MEDICATION, AND SUBSTANCE CLASSIFICATION SCHEDULE KHRC 8-020-1 (11/2018) Class A drugs, medications, and substances are those (1) that have the highest potential to influence performance in the equine athlete, regardless of their approval by the United States Food and Drug Administration, or (2) that lack approval by the United States Food and Drug Administration but have pharmacologic effects similar to certain Class B drugs, medications, or substances that are approved by the United States Food and Drug Administration. Acecarbromal Bolasterone Cimaterol Divalproex Fluanisone Acetophenazine Boldione Citalopram Dixyrazine Fludiazepam Adinazolam Brimondine Cllibucaine Donepezil Flunitrazepam Alcuronium Bromazepam Clobazam Dopamine Fluopromazine Alfentanil Bromfenac Clocapramine Doxacurium Fluoresone Almotriptan Bromisovalum Clomethiazole Doxapram Fluoxetine Alphaprodine Bromocriptine Clomipramine Doxazosin Flupenthixol Alpidem Bromperidol Clonazepam Doxefazepam Flupirtine Alprazolam Brotizolam Clorazepate Doxepin Flurazepam Alprenolol Bufexamac Clormecaine Droperidol Fluspirilene Althesin Bupivacaine Clostebol Duloxetine Flutoprazepam Aminorex Buprenorphine Clothiapine Eletriptan Fluvoxamine Amisulpride Buspirone Clotiazepam Enalapril Formebolone Amitriptyline Bupropion Cloxazolam Enciprazine Fosinopril Amobarbital Butabartital Clozapine Endorphins Furzabol Amoxapine Butacaine Cobratoxin Enkephalins Galantamine Amperozide Butalbital Cocaine Ephedrine Gallamine Amphetamine Butanilicaine Codeine
    [Show full text]
  • Panacea Or Pipe Dream: Does Portugal's Drug Decriminalization Policy Translate for Hawaii? Honolulu, HI: Legislative Reference Bureau, January 2017
    PANACEA OR PIPE DREAM: DOES PORTUGAL’S DRUG DECRIMINALIZATION POLICY TRANSLATE FOR HAWAII? Primary Researchers: PAUL KANOHO JOHNNY BRANNON MATTHEW PRELLBERG Research Attorneys Supervising Researcher: EDWIN L. BAKER Senior Researcher Report No. 1, 2017 Legislative Reference Bureau State Capitol Honolulu, Hawaii http://lrbhawaii.org This report has been cataloged as follows: Kanoho, Paul + Brannon, Johnny + Prellberg, Matthew + Baker, Edwin L. Panacea or pipe dream: does Portugal's drug decriminalization policy translate for Hawaii? Honolulu, HI: Legislative Reference Bureau, January 2017. 1. Drug legalization – Portugal. 2. Drug legalization – Hawaii. KFH421.5 L35 A25 17-1 FOREWORD This report was prepared in response to House Concurrent Resolution No. 127, H.D. 1, S.D. 1 (2016), which requested the Legislative Reference Bureau to analyze the potential impact on state government of decriminalizing certain offenses regarding the illegal possession of drugs. The Bureau requested information from federal, state, county, and private entities and individuals to complete this study. The Bureau extends its appreciation to all those that generously provided information and assistance in the preparation of this report. Charlotte A. Carter-Yamauchi Director January 2017 iii Table of Contents Page FOREWORD ......................................................................................................................... iii EXECUTIVE SUMMARY ..................................................................................................
    [Show full text]
  • Perspectives in Drug Discovery a Collection of Essays on the History and Development of Pharmaceutical Substances
    Perspectives in Drug Discovery A Collection of Essays on the History and Development of Pharmaceutical Substances Professor Alan Wayne Jones Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine Perspectives in Drug Discovery A Collection of Essays on the History and Development of Pharmaceutical Substances Professor Alan Wayne Jones Department of Forensic Genetics and Forensic Toxicology National Board of Forensic Medicine Perspectives in Drug Discovery A Collection of Essays on the History and Development of Pharmaceutical Substances Professor Alan Wayne Jones Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine Artillerigatan 12 • SE-587 58 Linköping • Sweden E-mail: [email protected] Internet: www.rmv.se RMV-report 2010:1 ISSN 1103-7660 Copyright © 2010 National Board of Forensic Medicine and Professor Alan Wayne Jones Design and graphic original: Forma Viva, Linköping • Sweden Printed by Centraltryckeriet, Linköping • Sweden, October 2010 Contents Preface Introduction 1. The First Sedative Hypnotics . 13 2. The Barbiturates ......................... 19 3. The Benzodiazepines ..................... 25 4. Narcotic Analgesics . 31 5. Central Stimulant Amines . 39 6. The First Antidepressants .................. 45 7. Antipsychotic Medication ................. 51 8. Aspirin and Other NSAID .................. 59 9. General Anesthetics . 65 10. SSRI Antidepressants . 71 11. Histamine Antagonists .................... 79 12. Anticonvulsants ......................... 87
    [Show full text]
  • Stembook 2018.Pdf
    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]
  • Drug/Substance Trade Name(S)
    A B C D E F G H I J K 1 Drug/Substance Trade Name(s) Drug Class Existing Penalty Class Special Notation T1:Doping/Endangerment Level T2: Mismanagement Level Comments Methylenedioxypyrovalerone is a stimulant of the cathinone class which acts as a 3,4-methylenedioxypyprovaleroneMDPV, “bath salts” norepinephrine-dopamine reuptake inhibitor. It was first developed in the 1960s by a team at 1 A Yes A A 2 Boehringer Ingelheim. No 3 Alfentanil Alfenta Narcotic used to control pain and keep patients asleep during surgery. 1 A Yes A No A Aminoxafen, Aminorex is a weight loss stimulant drug. It was withdrawn from the market after it was found Aminorex Aminoxaphen, Apiquel, to cause pulmonary hypertension. 1 A Yes A A 4 McN-742, Menocil No Amphetamine is a potent central nervous system stimulant that is used in the treatment of Amphetamine Speed, Upper 1 A Yes A A 5 attention deficit hyperactivity disorder, narcolepsy, and obesity. No Anileridine is a synthetic analgesic drug and is a member of the piperidine class of analgesic Anileridine Leritine 1 A Yes A A 6 agents developed by Merck & Co. in the 1950s. No Dopamine promoter used to treat loss of muscle movement control caused by Parkinson's Apomorphine Apokyn, Ixense 1 A Yes A A 7 disease. No Recreational drug with euphoriant and stimulant properties. The effects produced by BZP are comparable to those produced by amphetamine. It is often claimed that BZP was originally Benzylpiperazine BZP 1 A Yes A A synthesized as a potential antihelminthic (anti-parasitic) agent for use in farm animals.
    [Show full text]
  • Uniform Classification Guidelines for Foreign Substances, Version 7.00
    Association of Racing Commissioners International, Inc. Drug Testing Standards and Practices Program Model Rules Guidelines Uniform Classification Guidelines for Foreign Substances and Recommended Penalties and Model Rule Version 7.00 Revised January 2014 Association of Racing Commissioners International, Inc. Uniform Classification Guidelines for Foreign Substances Table of Contents Preamble to the Uniform Classification Guidelines of Foreign Substances ..................................................................................... ii Notes Regarding Classification Guidelines ...................................................................................................................................... ii Classification Criteria ....................................................................................................................................................................... iii Classification Definitions ................................................................................................................................................................. iv Drug Classification Scheme ............................................................................................................................................................. vi Alphabetical Substance List ............................................................................................................................................................... 1 Listing by Classification ..................................................................................................................................................................
    [Show full text]
  • Psychotropic Substances, Statistics for 2011, Assessments of Annual
    Part two Deuxième partie Segunda parte COMMENTS ON THE REPORTED statistics ON Psychotropic Substances Summary The analysis contained in the present section of the technical publication is based on statistical data furnished by Governments. The quality of the analysis depends on the data provided. Use of substances included in Schedule I of the 1971 Convention should be limited to scientific research and, in certain cases, the manufacture of psychotropic substances in other schedules. The isolated use of some substances in Schedule I for the manufacture of other substances has declined in recent years. Manufacture of methylphenidate and its use for the treatment of attention-deficit hyperactiv- ity disorder (ADHD) continue to increase worldwide. Although the number of countries reporting manufacture of methylphenidate has increased in recent years, the United States of America remains the leading manufacturer. In 2011, per capita consumption of methylphenidate (calculated by the Board or reported by Governments, pursuant to Commission on Narcotic Drugs resolu- tion 54/6) was highest in Canada, Costa Rica, Iceland, Israel, the Netherlands, Norway, Sweden and the United States. English Manufacture of amphetamines, the other central nervous system stimulants in Schedule II of the 1971 Convention, increased slightly in 2011 compared with 2010. Nevertheless, in 2011 the combined total of global manufacture of these substances amounted to only half of the amount reported about a decade ago. The United States remained the largest consumer of amphetamines in 2011 in absolute terms, as well as in terms of per capita consumption. Buprenorphine, an opioid analgesic listed in Schedule III of the 1971 Convention, has been increasingly used in the treatment of pain and substitution treatment for opioid addicts since the late 1990s.
    [Show full text]
  • THE NATIONAL CONGRESS DECREES: Chapter I General Rules
    LAW NO. 1008 OF 19 JULY 1988 ON THE REGIME APPLICABLE TO COCA AND CONTROLLED SUBSTANCES Whereas the National Congress has ratified the following Law: THE NATIONAL CONGRESS DECREES: TITLE I THE REGIME APPLICABLE TO COCA Chapter I General rules, nature and definitions Article 1 . Coca, which belongs to the genus erythroxylon, is a natural subtropical product of the Departments of La Paz and Cochabamba. It grows wild and is also cultivated, and dates back to the pre-Columbian period of Bolivian history. Article 2. Coca-growing is an agricultural and cultural activity that has been traditionally oriented in a legitimate manner towards consumption and to use in medicine and in rituals of the Andean peoples. Article 3. For legal purposes, an essential difference is made between coca in its natural state, which does not produce harmful effects on human health, and coca " iter criminis", that is to say, the leaf in the process of chemical transformation, isolating the alkaloid cocaine, which produces harmful psychological, physiological and biological effects on human health. Article 4. Legal consumption and use of the coca leaf are understood to mean the social and cultural practices of the Bolivian people in traditional forms, such as acullicu and chewing and medicinal and ritual uses. Article 5. Other forms of legal use of the coca leaf that do not harm health or lead to any type of drug dependence or addiction, as well as industrial processing for legal use, shall be subject to special regulation. Article 6. The production of coca leaf that covers demand for the uses and consumption referred to in articles 4 and 5 is defined as necessary production.
    [Show full text]
  • Fdrlrgse O.5,N.16/Mnajl ,18 Oie Federal Register / Vol. 50, No. 126
    27064 Federal Register / Vol. 50, No. 126 / Monday, July 1, 1985 / Notices 27064 FdrlRgse o.5,N.16/MnaJl ,18 oie the apparent conditions of its use. Upon Drugs will enter summary judgment Convention on Psychotropic Substances. finalization of the withdrawal of against the person(s) who request(s) the Article 2 of the Convention on approvals of the applications identified hearing, making findings and Psychotropic Substances provides that if above, the corresponding regulation conclusions, and denying a hearing. WHO has information about a All shall be revoked as provided in section submissions under this notice substance which in its opinion may 512(i) of the act (21 U.S.C. 360b(i)) (21 shall be filed in four copies. All require international control or change CFR 555.110c). submissions under this notice, except for in such control, it shall so notify the In accordance with provisions of data and information prohibited from Secretary-General of the United Nations section 512 of the act (21 U.S.C. 360b) public disclosure under section 301(j) of and provide the Secretary-General with and regulations promulgated under it (21 the act (21 U.S.C. 331(j)) or 18 U.S.C. information in support of its opinion. CFR Part 514) and under authority 1905, may be seen in the Dockets The Controlled Substances Act (CSA) delegated to him by 21 CFR 5.84, the Management Branch (address above) (21 U.S.C. 801 et seq.) provides that Director hereby provides an opportunity between 9 a.m. and 4 p.m., Monday when WHO notifies the United States for hearing to show why approval of the through Friday.
    [Show full text]
  • Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule
    DRUG TESTING STANDARDS AND PRACTICES PROGRAM. Uniform Classification Guidelines for Foreign Substances And Recommended Penalties Model Rule. January, 2018 (V.13.4) ASSOCIATION OF RACING COMMISSIONERS INTERNATIONAL – 2018. Association of Racing Commissioners International 1510 Newtown Pike, Lexington, Kentucky, United States www.arci.com Page 1 of 61 Preamble to the Uniform Classification Guidelines of Foreign Substances The Preamble to the Uniform Classification Guidelines was approved by the RCI Drug Testing and Quality Assurance Program Committee (now the Drug Testing Standards and Practices Program Committee) on August 26, 1991. Minor revisions to the Preamble were made by the Drug Classification subcommittee (now the Veterinary Pharmacologists Subcommittee) on September 3, 1991. "The Uniform Classification Guidelines printed on the following pages are intended to assist stewards, hearing officers and racing commissioners in evaluating the seriousness of alleged violations of medication and prohibited substance rules in racing jurisdictions. Practicing equine veterinarians, state veterinarians, and equine pharmacologists are available and should be consulted to explain the pharmacological effects of the drugs listed in each class prior to any decisions with respect to penalities to be imposed. The ranking of drugs is based on their pharmacology, their ability to influence the outcome of a race, whether or not they have legitimate therapeutic uses in the racing horse, or other evidence that they may be used improperly. These classes of drugs are intended only as guidelines and should be employed only to assist persons adjudicating facts and opinions in understanding the seriousness of the alleged offenses. The facts of each case are always different and there may be mitigating circumstances which should always be considered.
    [Show full text]
  • KENTUCKY HORSE RACING Chapter: \810\008.020REG
    PUBLIC PROTECTION CABINET Kentucky Horse Racing Commission (Amendment) 810 KAR 8:020. Drug, medication, and substance classification schedule [and with- drawal guidelines]. RELATES TO: KRS 230.215, 230.225, 230.240, 230.260, 230.265, 230.290, 230.320, 230.370 STATUTORY AUTHORITY: KRS 230.215(2), 230.225, 230.240(2), 230.260, 230.320, 230.370 NECESSITY, FUNCTION, AND CONFORMITY: KRS 230.215(2) authorizes the Kentucky Horse Racing Commission (the “commission”) to promulgate administrative regulations pre- scribing conditions under which all legitimate horse racing and wagering thereon is conducted in Kentucky. KRS 230.240(2) requires the commission to promulgate administrative regula- tions restricting or prohibiting the administration of drugs or stimulants or other improper acts to horses prior to the horse participating in a race. This administrative regulation establishes the drug classification schedule in effect in Kentucky[and the withdrawal guidelines] for permitted drugs, medications, and substances that may be administered to race horses competing in Kentucky. Section 1. The Kentucky Horse Racing Commission Uniform Drug, Medication, and Sub- stance Classification Schedule.[, KHRC 8-020-1,] (1) This administrative regulation shall establish the respective classifications of all sub- stances contained herein[therein. The Kentucky Horse Racing Commission Withdrawal Guide- lines Thoroughbred; Standardbred; Quarter Horse, Appaloosa, and Arabian, KHRC 8-020-2, shall provide certain mandatory treatment requirements and guidance and advice on with- drawal intervals as contained therein]. (2)(a) Class A drugs, medications, and substances are those that: 1. Have the highest potential to influence performance in the equine athlete, regardless of their approval by the United States Food and Drug Administration; or 2.
    [Show full text]